Eric Chen

Eric Chen

Company: Achelois Biopharma

Job title: CEO


Engineering Tumor-Targeting T-Cells to Overcome the Tolerance Barriers in Cancer Treatment 2:00 pm

Exploring genetic-enhancing modifiers (GEMs) as a platform to modify TIL function and the TME Enhancing TIL killing and persistence in the TME through modulationRead more

day: Conference Day One - Track A - PM

A Hanson Wade Group Company

© Copyright 2024 Hanson Wade | Design and site by Event Engine | Hanson Wade Limited is registered in England & Wales, number 06752216.
Registered Office: Eastcastle House, 27/28 Eastcastle Street, London, W1W 8DH.